Susan A. Miller, MD, MBA
- Assistant Professor of Pediatrics
Miller’s clinical area of expertise is pediatric cardiology with a special focus on pediatric cardiac transplantation, heart failure, cardiomyopathy, pulmonary hypertension and cardiac catheterization. Miller’s mission is to improve outcomes and treatment options for patients with congenital heart disease, pediatric heart failure and cardiomyopathy undergoing thoracic transplantation therapies.
Miller has long been a greatly appreciated senior faculty member in the Division of Cardiology, Department of Pediatrics. She is actively engaged in teaching, patient care and clinical service functions. Her career goals and accomplishments have been in clinical based teaching and clinical program development in pediatric heart transplantation, pediatric heart failure, cardiomyopathy, the cardiac catheterization lab and pulmonary artery hypertension.
Miller received her undergraduate degree at Bucknell University and her MD degree at the University of Pittsburgh. Her pediatric training was completed at Children’s Hospital of Pittsburgh with an extra year spent at the King Edward VIII hospital in Durban, South Africa due to her interest in international medicine. She then worked at the Hospital Albert Schweitzer in Deshapelle, Haiti for 18 months as one of three pediatricians serving a population of 300,000. Working in Haiti, Miller completed her master’s in business administration at the University of Pittsburgh Katz School of Business just prior to starting her cardiology fellowship. Miller completed her pediatric cardiology training at Children’s Hospital of Pittsburgh.
She received the Excellence in Teaching Award from Pediatric Cardiology Fellows. She was board certified by the American Board of Pediatrics, General Pediatrics in 1987 and Pediatric Cardiology in 1992, and currently maintains active certification in both.
Professional and Scientific Society Memberships
- American Academy of Pediatrics, 1982-1986, 1989-1994
- American Heart Association Council on Cardiovascular Disease in the Young,1989-1992, 2018-Present
- International Pediatric Transplant Association, 2003-2016
- International Society for Heart and Lung Transplantation, 2000-2005
- Pediatric Cardiomyopathy Foundation, 2017-Present
- Heart Failure Society of America, 2018-Present
- Pediatric Pulmonary Hypertension Network, 2019-Present
Education & Training
- BA, Biology, Bucknell University, 1978
- MD, University of Pittsburgh School of Medicine, 1982
- MBA, University of Pittsburgh Katz School of Business Administration, 1989
- Internship in Pediatrics, UPMC Children's Hospital of Pittsburgh, 1982-1983
- Residency in Pediatrics, UPMC Children's Hospital of Pittsburgh, 1984-1986
- Fellowship in Pediatric Cardiology, UPMC Children's Hospital of Pittsburgh, 1989-1992
Magnetta DA, Godown J, West SC, Zinn M, Miller S, Feingold B. Impact of the 2016 Revision of US Pediatric Heart Allocation Policy on Waitlist Characteristics and Outcomes. Am J Transplant. Dec 2019; 19(12):3276-83. PMID: 31544351.
West SC, Webber SA, Zeevi A, Miller SA, Morell VO, Feingold B. Charges and resource utilization for pediatric heart transplantation across a positive virtual and/or cytotoxicity crossmatch. Pediatr Transplant. 2018 Feb;22(1):e13095. PubMed PMID: 29250877.
Feingold B, Salgado CM, Reyes-Múgica M, Drant SE, Miller SA, Kennedy M, Kellman P, Schelbert EB, Wong TC. Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: Correlation of histology, cardiovascular magnetic resonance, and clinical phenotype. Pediatr Transplant. 2017 Aug;21(5): e12986. PubMed PMID: 28574157.
Xu Y, Galambos C, Reyes-Múgica M, Miller SA, Zeevi A, Webber SA, Feingold B. Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation. J Heart Lung Transplant 2013; 32:92-7.
Jooste EH, Muhly WT, Ibinson JW, Suresh T, Damian D, Phadke A, Callahan P, Miller S, Feingold B, Lichtenstein SE, Cain JG, Chrysostomou C, Davis PJ. Acute hemodynamic changes after rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization. Anesth Analg. 2010 Dec;111(6):1490-6. PubMed PMID: 21059743
Bingler MA, Feingold B, Miller SA, Quivers ES, Michaels MG, Green M, Wadowsky RM, Rowe DT, Webber SA. Chronic High Epstein-Barr Viral Load State and Risk for Late Onset Post-Transplant Lymphoproliferative Disease / Lymphoma in Children. Am J Transplant 2008; 8(2):442-5.
Feingold B, Olesnevich PJ, Girnita A, Zeevi A, Miller SA, Quivers ES, Webber SA. Survival in Allosensitized Children After Listing for Cardiac Transplantation. J Heart Lung Transplant 2007; 26:565–71.
Law YM, Yim R, Agatista P, Boyle GA, Miller SA, Lawrence K, Webber SA. Lipid Profiles in Pediatric Thoracic Recipients are Determined by Their Immunosuppressive Regimens. J Heart Lung Transplant 2006;25:276-282.
Di Filippo, Girnita A, Webber S, Tsao S, Boyle GJ, Miller SA, Gandhi SK, Zeevi A. Impact of ELISA-Detected Antibodies on Pediatric Cardiac Allograft Outcome. Human Immunology 2005;66:513-8.
Di Filippo, Zeevi A, McDade D, Boyle GJ, Miller SA, Gandhi SK, Webber SA. Impact of TGF1 gene polymorphisms on late renal function in pediatric heart transplantation. Human Immunology 2005;66:133-9.